Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
48
BNR Quote, Financials, Valuation and Earnings
Last price:
$19.73
Seasonality move
:
5.23%
Day range:
$19.50 - $21.17
52-week range:
$2.18 - $23.59
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.85x
P/B ratio:
3.32x
Volume:
43K
Avg. volume:
53.9K
1-year change:
187.77%
Market cap:
$215.3M
Revenue:
$71.7M
EPS (TTM):
-$1.61
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Burning Rock Biotech Ltd. has 95.59% upside to fair value with a price target of -- per share.
BNR vs. S&P 500
-
Over the past 5 trading days, Burning Rock Biotech Ltd. has underperformed the S&P 500 by -7.65% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Burning Rock Biotech Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Burning Rock Biotech Ltd. has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Burning Rock Biotech Ltd. reported revenues of $18.4M.
Earnings Growth
-
Burning Rock Biotech Ltd. has grown year-over-year earnings for 12 quarters straight. In the most recent quarter Burning Rock Biotech Ltd. reported earnings per share of -$0.22.
Enterprise value:
154.4M
EV / Invested capital:
1.89x
Price / LTM sales:
2.85x
EV / EBIT:
--
EV / Revenue:
2.07x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-33.19x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$54.6M
Return On Assets:
-13.84%
Net Income Margin (TTM):
-22.54%
Return On Equity:
-20.71%
Return On Invested Capital:
-18.96%
Operating Margin:
-12.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $79.3M | $70.9M | $74.7M | $17.9M | $18.4M | |
| Gross Profit | $54.8M | $34M | $54.6M | $12.8M | $13.8M | |
| Operating Income | -$102.1M | -$61.3M | -$12.4M | -$5.4M | -$2.3M | |
| EBITDA | -$97M | -$43.8M | -$6.8M | -$4.6M | -$2M | |
| Diluted EPS | -$9.80 | -$5.78 | -$1.61 | -$0.48 | -$0.22 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $308.4M | $191M | $132.4M | $111.9M | $103.9M | |
| Total Assets | $375.5M | $244.1M | $159.7M | $140.4M | $114.1M | |
| Current Liabilities | $47.6M | $51.2M | $40.4M | $36.8M | $33M | |
| Total Liabilities | $56.5M | $61M | $41.6M | $48M | $36.9M | |
| Total Equity | $319M | $183.2M | $118.1M | $92.4M | $77.2M | |
| Total Debt | $9M | $3.2M | $699.6K | $10.4M | $2.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$42.8M | -$9.1M | -$4.7M | -$4.1M | $2.2M | |
| Cash From Investing | -$2M | -$314.1K | -$683K | -$134.2K | -$381.8K | |
| Cash From Financing | -$7.9M | -$229.2K | $266.8K | $300 | $1.7K | |
| Free Cash Flow | -$42.8M | -$9.1M | -$4.7M | -$4.1M | $2.2M | |
BNR
Sector
Market Cap
$215.3M
$28.5M
Price % of 52-Week High
84.78%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
2.19%
-1.33%
1-Year Price Total Return
187.77%
-20.32%
Beta (5-Year)
1.199
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$20.80
200-day SMA
Buy
Level
$7.04
Bollinger Bands (100)
Buy
Level
6.23 - 14.17
Chaikin Money Flow
Sell
Level
-1.6M
20-day SMA
Buy
Level
$16.48
Relative Strength Index (RSI14)
Buy
Level
61.01
ADX Line
Buy
Level
49.39
Williams %R
Neutral
Level
-31.9395
50-day SMA
Buy
Level
$12.64
MACD (12, 26)
Buy
Level
2.62
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
660.8K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.5337)
Sell
CA Score
(Annual)
Level (-0.8384)
Buy
Beneish M-Score
(Annual)
Level (-3.5305)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (2.8698)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.
Stock Forecast FAQ
In the current month, BNR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BNR average analyst price target in the past 3 months is --.
-
Where Will Burning Rock Biotech Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Burning Rock Biotech Ltd. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Burning Rock Biotech Ltd.?
Analysts are divided on their view about Burning Rock Biotech Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Burning Rock Biotech Ltd. is a Sell and believe this share price will drop from its current level to --.
-
What Is Burning Rock Biotech Ltd.'s Price Target?
The price target for Burning Rock Biotech Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BNR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Burning Rock Biotech Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BNR?
You can purchase shares of Burning Rock Biotech Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Burning Rock Biotech Ltd. shares.
-
What Is The Burning Rock Biotech Ltd. Share Price Today?
Burning Rock Biotech Ltd. was last trading at $19.73 per share. This represents the most recent stock quote for Burning Rock Biotech Ltd.. Yesterday, Burning Rock Biotech Ltd. closed at $20.00 per share.
-
How To Buy Burning Rock Biotech Ltd. Stock Online?
In order to purchase Burning Rock Biotech Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BNR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BNR
Sector
P/E ratio
--
23.75x
PEG ratio
--
-0.01x
P/B ratio
3.32x
1.83x
Price / LTM sales
2.85x
1.60x
Growth Metrics
BNR
Sector
Revenue growth
2.46%
4.85%
Earnings growth
55.02%
11.11%
Revenue (5-year growth)
5.35%
6.45%
Earnings forecast
--
-$0.20
Profitability
BNR
Sector
Profitability FY 2024
$50.4M
$3.6M
Return on invested capital
-18.96%
-30.98%
Return on assets
-13.84%
-27.62%
Return on equity
-20.71%
-36.69%
Earnings Date
Last Earnings Date
May
28
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
BNR
Sector
Total cash
$65.6M
$27.2M
Short term investments
--
$25.7M
Total assets
$121.3M
$79.7M
Long term debt
$2.3M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 31.68% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 45.78% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.15% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
